首页> Critical reviews in oncogenesis> Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer.

Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Deepika,Sarvepalli

第一单位： Department of Internal Medicine, AdventHealth, Orlando, FL 32804.

作者： Deepika,Sarvepalli ^[1] ; Mamoon Ur,Rashid ^[2] ; Asad Ur,Rahman ^[3] ; Waqas,Ullah ^[4] ; Ishtiaq,Hussain ^[5] ; Badar,Hasan ^[3] ; Sundas,Jehanzeb ^[6] ; Abdul Kareem,Khan ^[1] ; Akriti Gupta,Jain ^[7] ; Neelam,Khetpal ^[7] ; Sarfraz,Ahmad ^[8]

作者单位： Department of Internal Medicine, AdventHealth, Orlando, FL 32804. ^[1] Department of Gastroenterology, Cleveland Clinic, Weston, Florida; Department of Internal Medicine, AdventHealth, Orlando, FL 32804. ^[2] Abington Hospital-Jefferson Health, Abington, Pennsylvania. ^[3] Khyber Teaching Hospital, Peshawar, Khyber Pakhtunkhwa, Pakistan; Abington Hospital - Jefferson Health, Abington, PA 19001, USA. ^[4] Abington Hospital-Jefferson Health, Abington, Pennsylvania; Department of Gastroenterology, Cleveland Clinic, Weston, FL 33331. ^[5] Khyber Teaching Hospital, Peshawar, Khyber Pakhtunkhwa 25000, Pakistan. ^[6] Department of Internal Medicine, AdventHealth, Orlando, Florida. ^[7] Department of Gynecologic Oncology, AdventHealth Cancer Institute, Orlando, FL 32804. ^[8]